Harnessing Breakthrough Science to Advance Hematology Care
Disc Medicine is a clinical-stage biopharmaceutical company committed to discovering, developing, and commercializing novel treatments for hematologic diseases. The company applies new insights in heme biosynthesis and iron metabolism to develop first-in-class therapies, including bitopertin for erythropoietic protoporphyria and DISC-0974 for myelofibrosis-associated anemia. Disc Medicine is listed on Nasdaq under the ticker IRON.
Tech & App Stack is available on paid plans
Upgrade to Silver or higher to reveal the full technology and app stack for any company.
View pricingCreate a free account to see funding visualizations and detailed round data.
Create Free AccountFeb 2023
Feb 2023
Oct 2019
Create a free account to see which investors have funded this company.
Create Free Account
Late-stage biopharma using single-molecule tracking, AI, and engineering to discover and develop ...
Asymchem provides R&D and one-stop production services to the world's top pharmaceutical companies.
South Korean biotech company and global leader in medical aesthetics, manufacturing botulinum tox...
Global full-service clinical research organization (CRO) and scientific advisory partner for biot...
Health insurance company using technology to make health care simple, affordable, and accessible.
Global clinical research organization specializing in early-stage clinical trials and bioanalytic...
